Table 3. Five-year DFS and OS according to the recourse to lymphadenectomy and adjuvant therapies.
Adiuvant therapy | No lymphadenectomy (n=89) | Pelvic+/-aortic lymphadenectomy (n=165) | ||
---|---|---|---|---|
5-Year DFS | 5-Year OS | 5-Year DFS | 5-Year OS | |
None | 62.39 | 79.17 | 64.41 | 76.61 |
EBRT | 70.73 | 75.61 | 67.56 | 79.35 |
Chemotherapy | 63.56 | 70.23 | 65.86 | 75.46 |
Sequential chemo- EBRT | 100 | 100 | 79.56 | 86.09 |
DFS, disease-free survival; EBRT, external beam radiotherapy; OS, overall survival.